The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Zebrafish as a model for drug induced liver injury: state of the art and beyond”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2024 |
M.I. Lucena, M. Villanueva-Paz, I. Alvarez-Alvarez, G.P. Aithal, E.S. Björnsson, G. Cakan-Akdogan, F.J. Cubero, F. Esteves, J.M. Falcon-Perez, B. Fromenty, C. Garcia-Ruiz, J.I. Grove, O. Konu, M. Kranendonk, G.A. Kullak-Ublick, J.P. Miranda, A. Remesal-Doblado, P. Sancho-Bru, L. Nelson, R.J. Andrade, A.K. Daly, J.C. Fernandez-Checa. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet, Pharmacological Research. 2024; 200: 107046107046. https://doi.org/10.1016/j.phrs.2023.107046 |
|
2 |
2025 |
Harika Eylül Esmer Duruel, Modeling the Effects of Environmental Pollutants on Metabolic Syndrome in Fish, Environmental Toxicology and Ecology. 2025; 5: 53. https://doi.org/10.59838/etoxec.1745448 |
|
3 |
2025 |
Ahmed Abu-Siniyeh, Moayad Khataibeh, Walid Al-Zyoud, Majed Al Holi. Zebrafish as a model for human epithelial pathology, Laboratory Animal Research. 2025; 41: 6. https://doi.org/10.1186/s42826-025-00238-6 |
|
4 |
2024 |
Chandrashekar Yashaswini, Neelakanta Sarvashiva Kiran, Ankita Chatterjee. Zebrafish navigating the metabolic maze: insights into human disease – assets, challenges and future implications, Journal of Diabetes & Metabolic Disorders. 2024; 24: 3. https://doi.org/10.1007/s40200-024-01539-8 |
|
5 |
2026 |
Shi‐Ying Huang, Guiling Li, Yi‐Jia Shih, Chang‐Wei Hsieh, Yun‐Sheng Lin, Jingwen Liu, Tao Sun, Chien‐Wei Feng. Determination of the Lethal Concentrations of Two Phenolic Acid Derivatives Originated From the Edible Red Marine Macroalga (Bangia fuscopurpurea) Using the In Vivo Zebrafish Eleutheroembryo Model and Their In Silico Structure–Toxicity Relationship Study, Food Science & Nutrition. 2026; 14: e71182. https://doi.org/10.1002/fsn3.71182 |